Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Kwong, P. D., Wyatt, R. T., Robinson, J. E., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,963

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,537

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623

Structure of influenza haemagglutinin at the pH of membrane fusion

Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994) · Nature · doi:10.1038/371037a0 · Cited by 1,564

An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex

García, K. C., Degano, M., Stanfield, R. L., Brunmark, A. B., Jackson, M. R., Peterson, P. A., Teyton, L., & Wilson, I. A. (1996) · Science · doi:10.1126/science.274.5285.209 · Cited by 1,301

Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus

Stevens, J., Blixt, O., Tumpey, T. M., Taubenberger, J. K., Paulson, J. C., & Wilson, I. A. (2006) · Science · doi:10.1126/science.1124513 · Cited by 941

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics

Kawaoka, Y., Krauss, S. L., & Webster, R. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4603-4608.1989 · Cited by 809

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

Kiso, M., Mitamura, K., Sakai‐Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 785

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

Throsby, M., van den Brink, E. N., Jongeneelen, M. A. C., Poon, L. L. M., Alard, P., Cornelissen, L. A. H. M., Bakker, A. Q., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 738

Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission

Valkenburg, S. A., Fang, V. J., Leung, N., Chu, D. K. W., Ip, D., Perera, R. A. P. M., Wang, Y., Li, A. P., Peiris, M. J. S., Cowling, B. J., et al. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1092 · Cited by 10

Influenza virus glycoprotein-reactive human monoclonal antibodies

Li, Y., Wang, L., Si, H., Yu, Z., Tian, S., Xiang, R., Deng, X., Liang, R., Jiang, S., & Yu, F. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.06.003 · Cited by 10

Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus

Li, S., Qiao, Y., Xu, Y., Li, P., Nie, J., Zhao, Q., Chai, W., Shi, Y., Kong, W., & Shan, Y. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1834579 · Cited by 10

Universal anti-influenza vaccines based on viral HA2 and M2e antigens

Kostolanský, F., Tomčíková, K., Briestenská, K., Mikušová, M., & Varečková, E. (2020) · Acta Virologica · doi:10.4149/av_2020_408 · Cited by 10

Influenza A H1 and H3 Transmembrane Domains Interact Differently with Each Other and with Surrounding Membrane Lipids

Kubiszewski-Jakubiak, S., & Worch, R. (2020) · Viruses · doi:10.3390/v12121461 · Cited by 10

Epitope-targeting platform for broadly protective influenza vaccines

Zeigler, D. F., Gage, E., & Clegg, C. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252170 · Cited by 11

Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies

Sei, C. J., Rao, M., Schuman, R. F., Daum, L. T., Matyas, G. R., Rikhi, N., Muema, K., Anderson, A., Jobe, O., Kroscher, K. A., et al. (2021) · Vaccines · doi:10.3390/vaccines9070698 · Cited by 10

A framework for predicting variable-length epitopes of human-adapted viruses using machine learning methods

Yin, R., Zhu, X., Zeng, M., Wu, P., Li, M., & Kwoh, C. K. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac281 · Cited by 10

B Cells and Functional Antibody Responses to Combat Influenza

Lofano, G., Kumar, A., Finco, O., Giudice, G. D., & Bertholet, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00336 · Cited by 11

Human monoclonal antibodies derived from a patient infected with 2009 pandemic influenza A virus broadly cross-neutralize group 1 influenza viruses

Pan, Y., Sasaki, T., Kubota‐Koketsu, R., Inoue, Y., Yasugi, M., Yamashita, A., Ramadhany, R., Arai, Y., Du, A., Boonsathorn, N., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.060 · Cited by 10

A universal flu vaccine.

Kęsik-Brodacka, M., & Płucienniczak, G. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1874 · Cited by 10

Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans

Lynch, G. W., Selleck, P., Church, W. B., & Sullivan, J. S. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.38 · Cited by 10

Some unmet challenges in the immunology of viral infections.

Rouse, B. T., & Lukacher, A. E. (2010) · PubMed · Cited by 10

Prediction of Antibody Epitopes

Nielsen, M., & Marcatili, P. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2999-3_4 · Cited by 10

Platform technology to generate broadly cross‐reactive antibodies to α‐helical epitopes in hemagglutinin proteins from influenza A viruses

Jiang, Z., Gera, L., Mant, C. T., Hirsch, B., Yan, Z., Shortt, J., Pollock, D. D., Qian, Z., Holmes, K. V., & Hodges, R. S. (2016) · Biopolymers · doi:10.1002/bip.22808 · Cited by 10

The challenges of a neglected STI: Molluscum contagiosum.

Zichichi, L., & Maniscalco, M. (2012) · PubMed · Cited by 10

Influenza vaccine—live

Luke, C. J., Lakdawala, S. S., & Subbarao, K. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00027-6 · Cited by 10

All for one and one for all to fight flu

Nabel, G. J., & Shiver, J. W. (2018) · Nature · doi:10.1038/d41586-018-07654-w · Cited by 9

Engineering an Antibody V Gene-Selective Vaccine

Ronsard, L., Yousif, A. S., Peabody, J., Okonkwo, V., Devant, P., Mogus, A. T., Barnes, R. M., Rohrer, D., Lönberg, N., Peabody, D. S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730471 · Cited by 9

Selective activation of naïve B cells with unique epitope specificity shapes autoantibody formation in celiac disease

Das, S., Stamnæs, J., Høydahl, L. S., Skagen, C., Lundin, K. E. A., Jahnsen, J., Sollid, L. M., & Iversen, R. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103241 · Cited by 9

How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza

Thompson, C., Steventon, R., & Stolle, L. (2025) · Antibodies · doi:10.3390/antib14010004 · Cited by 9

Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza

Selleck, G. W. L. P. (2009) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000036 · Cited by 9

Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice

Son, S., Ahn, S. B., Kim, G., Jang, Y., Ko, C., Kim, M., & Kim, S. J. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105591 · Cited by 9

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing

Jaishwal, P., Jha, K., & Singh, S. P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134012 · Cited by 10

Analysis of Antigenically Important Residues in Human Influenza A Virus in Terms of B-Cell Epitopes

Lees, W., Moss, D. S., & Shepherd, A. J. (2011) · Journal of Virology · doi:10.1128/jvi.00579-11 · Cited by 9

Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes

Magadán, J. G., Altman, M. O., Ince, W. L., Hickman, H. D., Stevens, J., Chevalier, A. A., Baker, D. A., Wilson, P. C., Ahmed, R., Bennink, J. R., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004204 · Cited by 9

Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells

Smet, A., Catani, J. P. P., Ysenbaert, T., Gonçalves, A. C., Kleanthous, H., Vogel, T. U., Saelens, X., & Job, E. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262873 · Cited by 9

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies

Cheung, C. Y., Dubey, S., Hadrovic, M., Ball, C. R., Ramage, W., McDonald, J. U., Harvey, R., Hufton, S. E., & Engelhardt, O. G. (2022) · Vaccines · doi:10.3390/vaccines10091473 · Cited by 9

Discordant Correlation between Serological Assays Observed When Measuring Heterosubtypic Responses against Avian Influenza H5 and H7 Viruses in Unexposed Individuals

Molesti, E., Ferrara, F., Lapini, G., Montomoli, E., & Temperton, N. J. (2014) · BioMed Research International · doi:10.1155/2014/231365 · Cited by 9

DNA-Epitope Vaccine Provided Efficient Protection to Mice Against Lethal Dose of Influenza A Virus H1N1

Wei, H., Lenz, S. D., Thompson, D. H., & Pogranichniy, R. M. (2014) · Viral Immunology · doi:10.1089/vim.2013.0080 · Cited by 9

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Leon, P. E., Wohlbold, T. J., He, W., Bailey, M. J., Henry, C., Wilson, P. C., Krammer, F., & Tan, G. S. (2017) · Journal of Visualized Experiments · doi:10.3791/56067 · Cited by 9

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors

Mathew, S., Thani, A. A. A., & Yassine, H. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203148 · Cited by 9

Development of a broad-spectrum subunit vaccine against H9N2 avian influenza using HA stem domain scaffold and snoopligase system

Quan, K., Zhang, N., Lin, M., Liu, Y., Li, Y., Hu, Q., Nie, M., Qin, T., Chen, S., Peng, D., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01191-0 · Cited by 8

A Pan-H5N1 Multiepitope DNA Vaccine Construct Targeting Some Key Proteins of the Clade 2.3.4.4b Using AI-Assisted Epitope Mapping and Molecular Docking

Duraisamy, N., Shah, A. U., Khan, M. Y., Cherkaoui, M., & Hemida, M. G. (2025) · Viruses · doi:10.3390/v17091152 · Cited by 8

Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies

Fischer, A. A. M., Corcoran, M., Brouwer, P. J. M., Chernyshev, M., Gillespie, R. A., Nicoletto, A., Loeffler, J. R., Ferguson, J. A., Zygouras, I., Pushparaj, P., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.03.002 · Cited by 10

Evolution in the influenza A H3 stalk – a challenge for broad-spectrum vaccines?

Lees, W., Moss, D. S., & Shepherd, A. J. (2013) · Journal of General Virology · doi:10.1099/vir.0.059410-0 · Cited by 8

Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice

Chowdhury, M. Y. E., Seo, S.-K., Moon, H.-J., Talactac, M. R., Kim, J., Park, M.-E., Son, H., Lee, J., & Kim, C. (2014) · Virology Journal · doi:10.1186/1743-422x-11-21 · Cited by 8

Optimization and SAR research at the benzoxazole and tetrazole rings of JNJ4796 as new anti-influenza A virus agents, part 2

Wu, W., Yan, H., Jiang, B., Wang, A., Li, X., Zhang, Y., Wu, J., Zhong, X., Gao, R., Wang, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114906 · Cited by 8

Mechanisms that promote the evolution of cross-reactive antibodies upon vaccination with designed influenza immunogens

Yang, L., Caradonna, T. M., Schmidt, A. G., & Chakraborty, A. K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112160 · Cited by 8

Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone

Medina, J., Boukhebza, H., Jean, A. D. S., Sodoyer, R., Legastelois, I., & Moste, C. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.112 · Cited by 8

Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of Influenza A virus

Dukhovlinov, I. V., Al-Shekhadat, R. I., Fedorova, E. A., Stepanova, L., Potapchuk, M. V., Репко, И. А., Rusova, O., Орлов, А. И., Tsybalova, L. M., & Киселев, О. И. (2013) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.884002 · Cited by 8

Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses

Sullivan, M., Kaur, K., Pauli, N. T., & Wilson, P. C. (2011) · F1000 Biology Reports · doi:10.3410/b3-17 · Cited by 9

Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice

Gray, S. A., Moore, M. D., VandenEkart, E., Roque, R., Bowen, R. A., Hoeven, N. V., Wiley, S. R., & Clegg, C. H. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.04.001 · Cited by 8

Modulation of Immunogenicity and Conformation of HA1 Subunit of Influenza A Virus H1/N1 Hemagglutinin in Tubular Immunostimulating Complexes

Михайловна, С. Н., Davydova, L., Chopenko, N. S., Kostetsky, E. Y., & Shnyrov, V. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091895 · Cited by 8

Cross-clade antibody reactivity may attenuate the ability of influenza virus to evade the immune response

Vashisht, S., Verma, S., & Salunke, D. M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.010 · Cited by 8

A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine

Li, Z. Y., Zaiser, S., Shang, P., Heiden, D. L., Hajovsky, H., Katwal, P., DeVries, B., Baker, J., Richt, J. A., Lǐ, Y., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108859 · Cited by 8

Apoferritin nanoparticle based dual-antigen influenza conjugate vaccine with potential cross-protective efficacy against heterosubtypic influenza virus

Sheng, Y., Wei, J., Li, Z., Su, Z. G., Ma, G., & Zhang, S. (2021) · Particuology · doi:10.1016/j.partic.2021.04.001 · Cited by 8

The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical Implications.

Vlachonikola, E., Sofou, E., Chatzidimitriou, A., Stamatopoulos, K., & Agathangelidis, A. (2021) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2021.03.003 · Cited by 7

Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats

Dong, C., & Wang, B. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100122 · Cited by 9

Nanodisc‐Mediated Conversion of Virustatic Antiviral Antibody to Disrupt Virus Envelope in Infected Cells

Hwang, J., Jung, Y., Moon, S., Yu, S., Oh, H., Kim, S., Kim, K. W., Yoon, J. H., Chun, J. M., Kim, S. J., et al. (2022) · Small Methods · doi:10.1002/smtd.202101516 · Cited by 8

Low Dose Pig Anti-Influenza Virus Monoclonal Antibodies Reduce Lung Pathology but Do Not Prevent Virus Shedding

Paudyal, B., McNee, A., Rijal, P., Carr, B. V., Núñez, A., McCauley, J. W., Daniels, R. S., Townsend, A., Hammond, J. A., & Tchilian, E. Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790918 · Cited by 8

Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice

Muralidharan, A., Gravel, C., Harris, G., Hashem, A. M., Zhang, W., Safronetz, D., Domselaar, G. V., Krammer, F., Sauvé, S., Rosu‐Myles, M., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2083428 · Cited by 8

Genome Stability of Pandemic Influenza A (H1N1) 2009 Based on Analysis of Hemagglutinin and Neuraminidase Genes

Espínola, E. E. (2012) · The Open Virology Journal · doi:10.2174/1874357901206010059 · Cited by 8

Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16–17 November 2011

Hughes, B., Hayden, F. G., Perikov, Y., Hombach, J., & Tam, J. S. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.073 · Cited by 8

Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus

Chin, R. A. D., Earnest-Silviera, L., Gordon, C. L., Olsen, K., Barr, I., Brown, L. E., Jackson, D. C., & Torresi, J. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.11.009 · Cited by 8

A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses

Boonsathorn, N., Panthong, S., Koksunan, S., Chittaganpitch, M., Phuygun, S., Waicharoen, S., Prachasupap, A., Sasaki, T., Kubota‐Koketsu, R., Yasugi, M., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.008 · Cited by 8

Identification of small molecules acting against H1N1 influenza A virus

Agamennone, M., Pietrantoni, A., & Superti, F. (2015) · Virology · doi:10.1016/j.virol.2015.11.024 · Cited by 8

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine

Cox, F., Saeland, E., Baart, M., Koldijk, M. H., Tolboom, J. T. B. M., Dekking, L., Koudstaal, W., Bengtsson, K. L., Goudsmit, J., & Radošević, K. (2015) · Virology Journal · doi:10.1186/s12985-015-0435-9 · Cited by 8

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+T Cell ActivationIn Vitrobut Not in C57BL/6 Mice

Altenburg, A. F., van de Sandt, C. E., Trierum, S. E. V.-V., Gruyter, H. L. M. D., van Run, P. R. W. A., Fouchier, R. A. M., Roose, K., Saelens, X., Volz, A., Sutter, G., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01633-16 · Cited by 8

Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice

Altenburg, A. F., Magnusson, S. E., Bosman, F., Stertman, L., de Vries, R. D., & Rimmelzwaan, G. F. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.13004 · Cited by 8

Monte Carlo simulations using PELE to identify a protein–protein inhibitor binding site and pose

Díaz, L., Soler, D., Tresadern, G., Buyck, C., Pérez‐Benito, L., Saen‐oon, S., Guallar, V., & Soliva, R. (2020) · RSC Advances · doi:10.1039/d0ra01127d · Cited by 10

Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head

Wang, Y., Hu, D., Wu, Y., & Ying, T. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0764-y · Cited by 8

A comprehensive laboratory animal facility pandemic response plan.

Roble, G. S., Lingenhol, N. M., Baker, B., Wilkerson, A., & Tolwani, R. J. (2010) · PubMed Central · Cited by 8

H1N1: Can a Pandemic Cycle Be Broken?

Settembre, E. C., Dormitzer, P. R., & Rappuoli, R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000948 · Cited by 8

A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular featuresPreprint

Wang, Y., Yuan, M., Peng, J., Wilson, I. A., & Wu, N. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.26.470157 · Cited by 8

An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody

Sano, K., Saito, S., Suzuki, T., Kotani, O., Ainai, A., van Riet, E., Tabata, K., Saito, K., Takahashi, Y., Yokoyama, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245244 · Cited by 7

Different Arms of the Adaptive Immune System Induced by a Combination Vaccine Work in Concert to Provide Enhanced Clearance of Influenza

Cobbin, J. C. A., Zeng, W., Jackson, D. C., & Brown, L. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115356 · Cited by 7

Epitope Binning of Monoclonal and Polyclonal Antibodies by Biolayer Interferometry

Nagashima, K. A., & Mousa, J. J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3239-0_2 · Cited by 7

Increasing sensitivity of antibody-antigen interactions using photo-cross-linking

de la Pena, A. T. T., Sewall, L. M., Rocha, R. D. P. F., Jackson, A., Pratap, P., Bangaru, S., Cottrell, C., Mohanty, S., Shaw, A., & Ward, A. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100509 · Cited by 8

HIV/AIDS: vaccines and alternate strategies for treatment and prevention

Voronin, Y., & Phogat, S. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05759.x · Cited by 7

Universal influenza vaccine: the holy grail?

SHAW, A. R. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.73 · Cited by 7

The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin

Щербинин, Д. Н., Alekseeva, S. V., Шмаров, М. М., Smirnov, Y. A., Naroditskiy, B. S., & Al, G. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-1-13-20 · Cited by 7

Microbial Cryptotopes are Prominent Targets of B-cell Immunity

Rieder, F. J. J., Biebl, J., Kastner, M.-T., Schneider, M., Jungbauer, C., Redlberger‐Fritz, M., Britt, W. J., Kundi, M., & Steininger, C. (2016) · Scientific Reports · doi:10.1038/srep31657 · Cited by 7

Stalking influenza

Eckert, D. M., & Kay, M. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008672107 · Cited by 7

Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates

Li, D., Wang, J., Garigen, J., Treanor, J. J., & Zand, M. S. (2019) · Computational and Mathematical Methods in Medicine · doi:10.1155/2019/9287120 · Cited by 7

Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin

Grødeland, G., Baranowska-Hustad, M., Abadejos, J. R., Blane, T. R., Teijaro, J. R., Nemazee, D. A., & Bogen, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00431 · Cited by 7

Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies

Sangesland, M., & Lingwood, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708882 · Cited by 7

Adjuvant-Mediated Differences in Antibody Responses to Computationally Optimized Hemagglutinin and Neuraminidase Vaccines

Nagashima, K. A., Abbadi, N., Vyas, V., Roegner, A., Ross, T. M., & Mousa, J. J. (2023) · Viruses · doi:10.3390/v15020347 · Cited by 7

Poultry Vaccine Technology Platforms

Bublot, M. (2023) · Avian Diseases · doi:10.1637/aviandiseases-d-23-99987 · Cited by 8

Mouse lung‐adapted mutation of E190G in hemagglutinin from H5N1 influenza virus contributes to attenuation in mice

Han, P., Hu, Y., Sun, W. Y., Zhang, S., Li, Y., Wu, X., Yang, Y., Zhu, Q., Jiang, T., Li, J., et al. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24257 · Cited by 7

A universal problem

Hoag, H. (2013) · Nature Medicine · doi:10.1038/nm0113-12 · Cited by 7

Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections

Vegvari, C., Cauët, E., Hadjichrysanthou, C., Lawrence, E., Weverling, G. J., de Wolf, F., & Anderson, R. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156622 · Cited by 8

The Francis Crick Institute

Peters, K., & Smith, J. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-2-105 · Cited by 7

Design and testing of a highly conserved human rotavirus VP8* immunogenic peptide with potential for vaccine development

Mohanty, E., Dehury, B., Satapathy, A. K., & Dwibedi, B. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.06.306 · Cited by 7

Oral immunization with an attenuated Salmonella Gallinarum encoding the H9N2 haemagglutinin and M2 ectodomain induces protective immune responses against H9N2 infection in chickens

Hajam, I. A., Kirthika, P., Hewawaduge, C., Jawalagatti, V., Park, S.-W., Senevirathne, A., & Lee, J. H. (2020) · Avian Pathology · doi:10.1080/03079457.2020.1775782 · Cited by 7

Transmission dynamics of influenza in two major cities of Uganda

Yang, W., Cummings, M. J., Bakamutumaho, B., Kayiwa, J. T., Owor, N., Namagambo, B., Byaruhanga, T., Lutwama, J. J., O’Donnell, M. R., & Shaman, J. L. (2018) · Epidemics · doi:10.1016/j.epidem.2018.03.002 · Cited by 7

Frequency of D222G haemagglutinin mutant of pandemic (H1N1) pdm09 influenza virus in Tunisia between 2009 and 2011

Moussi, A. E., Kacem, M. A. B. H., Pozo, F., Ledesma, J., Cuevas, M. T., Casas, I., & Slim, A. F. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-124 · Cited by 7

An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodiesPreprint

Wang, Y., Lv, H., Lei, R., Yeung, Y.-H., Shen, I. R., Choi, D., Teo, Q. W., Tan, T. J. C., Gopal, A. B., Chen, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.11.557288 · Cited by 7

HIV-1 neutralizing antibodies in SHIV-infected macaques recapitulate structurally divergent modes of human V2 apex recognition with a single D genePreprint

Roark, R. S., Habib, R., Gorman, J., Li, H. J., Connell, A. J., Bonsignori, M., Guo, Y., Hogarty, M. P., Olia, A. S., Sowers, K. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.11.598384 · Cited by 7

Structural basis for the broad antigenicity of the computationally optimized influenza hemagglutinin X6

Nagashima, K. A., Dzimianski, J. V., Yang, M., Abendroth, J. A., Sautto, G. A., Ross, T. M., DuBois, R. M., Edwards, T. E., & Mousa, J. J. (2024) · Structure · doi:10.1016/j.str.2024.05.001 · Cited by 6

Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle

Crofts, K. F., Holbrook, B. C., Page, C. L., Gillespie, R. A., D’Agostino, R. B., Sangesland, M., Ornelles, D. A., Kanekiyo, M., & Alexander‐Miller, M. A. (2025) · Nature Communications · doi:10.1038/s41467-025-59149-8 · Cited by 6

An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses

Ramesh, A. K., Sivaccumar, J. P., Ye, X., Yang, L., Guo, H., Chin, C., Ha, S., Shiver, J. W., Strohl, W. R., Xu, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59294-0 · Cited by 6

Dairy cattle herds mount a characteristic antibody response to highly pathogenic H5N1 avian influenza viruses

Robinson‐McCarthy, L. R., Simmons, H. C., Graber, A. L., Marble, C. N., Graudin, G. W., & McCarthy, K. R. (2025) · Journal of Virology · doi:10.1128/jvi.00621-25 · Cited by 6

Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaques

Sangesland, M., Li, N., Tsybovsky, Y., Rodgers, M. D., Han, J., Rodriguez, A. J., Ferguson, J. A., Henry, A. R., Smith, S. D., Roberts-Torres, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ady3570 · Cited by 6

Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus

Wang, Y., Li, X., Xu, Q., Niu, X., Zhang, S., Qu, X., Chu, H., Chen, J., Shi, Q., Zhang, E., et al. (2022) · Viruses · doi:10.3390/v14112530 · Cited by 6

A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants

Hao, T.-J., Li, Y.-L., Liu, P., Wang, X., Xu, K., Lei, W.-W., Li, Y., Zhang, R., Li, X., Zhao, X., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012508 · Cited by 5

Immunopaleontology reveals how affinity enhancement is achieved during affinity maturation of antibodies to influenza virus

Eisen, H. N., & Chakraborty, A. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219396110 · Cited by 6

An Universal Approach to Getting Ahead for Influenza B Vaccines

Kim, J. I., & Park, M. (2012) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2012.42.4.363 · Cited by 6

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity

Yang, Z., Liu, X., Sun, Z., Li, J., Tan, W., Yu, W., & Zhang, M.-Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02613 · Cited by 6

Stereotyped B-cell response that counteracts antigenic variation of influenza viruses

Tonouchi, K., Adachi, Y., Moriyama, S., Sano, K., Tabata, K., Ide, K., Takeyama, H., Suzuki, T., & Takahashi, Y. (2020) · International Immunology · doi:10.1093/intimm/dxaa038 · Cited by 6

A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses

Hu, H., Voss, J., Zhang, G., Buchy, P., Zuo, T., Wang, L., Wang, F., Zhou, F., Wang, G., Tsai, C., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06665-11 · Cited by 72

Research highlights

(2009) · Nature Biotechnology · doi:10.1038/nbt0409-348

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M. A. C., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 820

A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin

(2016)

An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells

Lee, C., Yang, C.-Y., Lin, L., Ko, T., Chang, A., Chang, S. S.-C., & Wang, A. H. ‐. (2019) · Scientific Reports · doi:10.1038/s41598-019-40937-4 · Cited by 22